vs

Dorman Products, Inc.(DORM)与Bio-Techne(TECH)财务数据对比。点击上方公司名可切换其他公司

Dorman Products, Inc.的季度营收约是Bio-Techne的1.8倍($537.9M vs $295.9M),Bio-Techne净利率更高(12.8% vs 2.1%,领先10.7%),Dorman Products, Inc.同比增速更快(0.8% vs -6.4%),过去两年Dorman Products, Inc.的营收复合增速更高(7.1% vs 4.2%)

多尔曼产品公司是美国知名的汽车售后配件制造商,成立于1918年,总部位于宾夕法尼亚州科尔马,在纳斯达克上市,股票代码为DORM,深耕汽车售后市场多年,为市场提供丰富的替换零部件产品。

Bio-Techne是美国头部生命科学企业,面向科研、诊断及生物工艺市场需求,研发、生产并销售生命科学试剂、仪器及配套服务,产品及解决方案广泛应用于基础研究、体外诊断、生物医药研发生产等场景,可为相关领域从业者提供可靠的专业工具支持。

DORM vs TECH — 直观对比

营收规模更大
DORM
DORM
是对方的1.8倍
DORM
$537.9M
$295.9M
TECH
营收增速更快
DORM
DORM
高出7.2%
DORM
0.8%
-6.4%
TECH
净利率更高
TECH
TECH
高出10.7%
TECH
12.8%
2.1%
DORM
两年增速更快
DORM
DORM
近两年复合增速
DORM
7.1%
4.2%
TECH

损益表 — Q4 FY2025 vs Q2 FY2026

指标
DORM
DORM
TECH
TECH
营收
$537.9M
$295.9M
净利润
$11.6M
$38.0M
毛利率
42.6%
64.6%
营业利润率
5.8%
18.4%
净利率
2.1%
12.8%
营收同比
0.8%
-6.4%
净利润同比
-78.8%
68.3%
每股收益(稀释后)
$0.38
$0.24

绿色 = 该指标领先。财年不对齐时期间可能不同

8季度营收与利润趋势

并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配

营收
DORM
DORM
TECH
TECH
Q4 25
$537.9M
$295.9M
Q3 25
$543.7M
Q2 25
$541.0M
$317.0M
Q1 25
$507.7M
$316.2M
Q4 24
$533.8M
$297.0M
Q3 24
$503.8M
$289.5M
Q2 24
$503.0M
$306.1M
Q1 24
$468.7M
$303.4M
净利润
DORM
DORM
TECH
TECH
Q4 25
$11.6M
$38.0M
Q3 25
$76.4M
Q2 25
$58.7M
$-17.7M
Q1 25
$57.5M
$22.6M
Q4 24
$54.5M
$34.9M
Q3 24
$55.3M
$33.6M
Q2 24
$47.4M
$40.6M
Q1 24
$32.8M
$49.1M
毛利率
DORM
DORM
TECH
TECH
Q4 25
42.6%
64.6%
Q3 25
44.4%
Q2 25
40.6%
62.7%
Q1 25
40.9%
67.9%
Q4 24
41.5%
65.3%
Q3 24
40.5%
63.2%
Q2 24
39.6%
66.4%
Q1 24
38.7%
67.4%
营业利润率
DORM
DORM
TECH
TECH
Q4 25
5.8%
18.4%
Q3 25
19.4%
Q2 25
15.2%
-7.5%
Q1 25
15.8%
12.2%
Q4 24
16.3%
16.0%
Q3 24
15.7%
13.8%
Q2 24
14.4%
15.0%
Q1 24
11.6%
22.1%
净利率
DORM
DORM
TECH
TECH
Q4 25
2.1%
12.8%
Q3 25
14.1%
Q2 25
10.9%
-5.6%
Q1 25
11.3%
7.1%
Q4 24
10.2%
11.7%
Q3 24
11.0%
11.6%
Q2 24
9.4%
13.3%
Q1 24
7.0%
16.2%
每股收益(稀释后)
DORM
DORM
TECH
TECH
Q4 25
$0.38
$0.24
Q3 25
$2.48
Q2 25
$1.91
$-0.11
Q1 25
$1.87
$0.14
Q4 24
$1.76
$0.22
Q3 24
$1.80
$0.21
Q2 24
$1.53
$0.26
Q1 24
$1.05
$0.31

资产负债表与财务实力

最新季度各公司的流动性、杠杆与账面价值一览

指标
DORM
DORM
TECH
TECH
现金及短期投资手头流动性
$49.4M
$172.9M
总债务越低越好
$440.6M
$260.0M
股东权益账面价值
$1.5B
$2.0B
总资产
$2.5B
$2.5B
负债/权益比越低杠杆越低
0.30×
0.13×

8季度趋势,按日历期对齐

现金及短期投资
DORM
DORM
TECH
TECH
Q4 25
$49.4M
$172.9M
Q3 25
$55.5M
Q2 25
$56.8M
$162.2M
Q1 25
$60.6M
$140.7M
Q4 24
$57.1M
$177.5M
Q3 24
$45.1M
$187.5M
Q2 24
$47.5M
$152.9M
Q1 24
$34.4M
$145.3M
总债务
DORM
DORM
TECH
TECH
Q4 25
$440.6M
$260.0M
Q3 25
Q2 25
$346.0M
Q1 25
$330.0M
Q4 24
$468.8M
$300.0M
Q3 24
$300.0M
Q2 24
$319.0M
Q1 24
$389.0M
股东权益
DORM
DORM
TECH
TECH
Q4 25
$1.5B
$2.0B
Q3 25
$1.5B
Q2 25
$1.4B
$1.9B
Q1 25
$1.3B
$2.0B
Q4 24
$1.3B
$2.1B
Q3 24
$1.2B
$2.1B
Q2 24
$1.2B
$2.1B
Q1 24
$1.2B
$2.0B
总资产
DORM
DORM
TECH
TECH
Q4 25
$2.5B
$2.5B
Q3 25
$2.6B
Q2 25
$2.5B
$2.6B
Q1 25
$2.4B
$2.6B
Q4 24
$2.4B
$2.7B
Q3 24
$2.4B
$2.7B
Q2 24
$2.3B
$2.7B
Q1 24
$2.2B
$2.7B
负债/权益比
DORM
DORM
TECH
TECH
Q4 25
0.30×
0.13×
Q3 25
Q2 25
0.18×
Q1 25
0.16×
Q4 24
0.36×
0.14×
Q3 24
0.14×
Q2 24
0.15×
Q1 24
0.19×

现金流与资本效率

扣除再投资后实际产生的现金。现金流比净利润更难造假

指标
DORM
DORM
TECH
TECH
经营现金流最新季度
$41.6M
自由现金流经营现金流 - 资本支出
$33.5M
自由现金流率自由现金流/营收
6.2%
资本支出强度资本支出/营收
1.5%
现金转化率经营现金流/净利润
3.60×
过去12个月自由现金流最近4个季度
$75.7M

8季度趋势,按日历期对齐

经营现金流
DORM
DORM
TECH
TECH
Q4 25
$41.6M
Q3 25
$12.2M
Q2 25
$8.5M
$98.2M
Q1 25
$51.2M
$41.1M
Q4 24
$71.4M
$84.3M
Q3 24
$44.3M
$63.9M
Q2 24
$63.3M
$75.5M
Q1 24
$52.0M
$81.0M
自由现金流
DORM
DORM
TECH
TECH
Q4 25
$33.5M
Q3 25
$1.8M
Q2 25
$98.0K
$93.3M
Q1 25
$40.3M
$31.0M
Q4 24
$63.2M
$77.5M
Q3 24
$35.7M
$54.7M
Q2 24
$51.4M
$57.5M
Q1 24
$41.2M
$64.5M
自由现金流率
DORM
DORM
TECH
TECH
Q4 25
6.2%
Q3 25
0.3%
Q2 25
0.0%
29.4%
Q1 25
7.9%
9.8%
Q4 24
11.8%
26.1%
Q3 24
7.1%
18.9%
Q2 24
10.2%
18.8%
Q1 24
8.8%
21.3%
资本支出强度
DORM
DORM
TECH
TECH
Q4 25
1.5%
Q3 25
1.9%
Q2 25
1.6%
1.5%
Q1 25
2.2%
3.2%
Q4 24
1.5%
2.3%
Q3 24
1.7%
3.2%
Q2 24
2.4%
5.9%
Q1 24
2.3%
5.4%
现金转化率
DORM
DORM
TECH
TECH
Q4 25
3.60×
Q3 25
0.16×
Q2 25
0.15×
Q1 25
0.89×
1.82×
Q4 24
1.31×
2.42×
Q3 24
0.80×
1.90×
Q2 24
1.34×
1.86×
Q1 24
1.58×
1.65×

财务流量对比

营收 → 毛利润 → 营业利润 → 净利润流向图

业务分部营收拆解

DORM
DORM

Light Duty$428.6M80%
Heavy Duty$55.8M10%
Specialty Vehicle$53.5M10%

TECH
TECH

Diagnostics And Spatial Biology$81.2M27%
EMEA Excluding UK$75.4M25%
Other$42.4M14%
Instruments$29.6M10%
APAC Excluding Greater China$22.7M8%
Services$22.3M8%
GB$13.7M5%
Royalty$8.5M3%

相关对比